Study Suggests Possible Connection Between GLP-1 Medications and Rare Brain Condition

There’s a new study that’s raised some eyebrows—particularly among those using popular GLP-1 weight-loss drugs like Ozempic and Wegovy. Researchers have linked these medications to a rare but serious brain condition known as Wernicke encephalopathy, which is tied to a significant deficiency of vitamin B1.

This study, published in Clinical Nutrition, detailed 15 cases of this neurological disorder in patients taking GLP-1 receptor agonists. Most of these instances were reported among users of semaglutide or tirzepatide. It’s kind of alarming, really, especially since these medications have gained so much popularity recently.

By examining the FDA’s Adverse Event Reporting System, along with medical literature and data from their own medical center, researchers confirmed these cases. Interestingly, many of the patients experienced gastrointestinal symptoms or other nutritional issues such as weight loss, vomiting, and loss of appetite.

The disorder appeared more frequently in people who were using GLP-1 medications than in those taking other types of drugs. However, it’s important to note that the study doesn’t establish a direct cause-and-effect relationship.

Vitamin B1 is crucial for brain function, and a lack of it can lead to confusion, difficulty walking, and even vision problems. If untreated, this deficiency can result in severe neurological damage or even death.

Karthik Achari, a clinician based in Chicago, emphasizes that while this discovery is significant, it’s essential to keep things in perspective. The fact that only 15 cases were identified among millions of users makes it a relatively rare issue. On one hand, that might be comforting—on the other, those 15 cases certainly deserve attention.

Achari points out that GLP-1 medications can suppress appetite and cause nausea, inadvertently leading some patients to not consume enough vitamin B1. After all, the medication reduces hunger but doesn’t adjust your body’s nutritional needs.

He explains, “You can eat very little without realizing it, which can be the goal, but your body’s requirements for nutrients stay the same.” This means those experiencing ongoing nausea, rapid weight loss, or anyone with a history of gastric bypass surgery or heavy alcohol use might be at a greater risk.

Nutrition expert Erin Palinski-Wade also stresses the importance of maintaining proper nutrition and hydration while on these medications. She notes that although appetite suppression can be beneficial, it can also lead to unintentional under-consumption of essential nutrients, particularly proteins and fluids.

Palinski-Wade recommends that patients remain vigilant about their health, especially in light of ongoing digestive issues. She advises seeking medical care if severe symptoms last for about a day, underscoring that not every side effect is just part of the medication.

While this study does raise significant concerns, the authors also acknowledge the limitations in their findings. Conclusively proving that GLP-1 medications caused these cases isn’t possible based on the data collected. They have called for more research in the area, urging that patients shouldn’t stop taking their prescribed medications without consulting their healthcare providers first.